BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Kongtawelert P, Tangkijvanich P, Ong-Chai S, Poovorawan Y. Role of serum total sialic acid in differentiating cholangiocarcinoma from hepatocellular carcinoma. World J Gastroenterol 2003; 9(10): 2178-2181 [PMID: 14562373 DOI: 10.3748/wjg.v9.i10.2178]
URL: https://www.wjgnet.com/1007-9327/full/v9/i10/2178.htm
Number Citing Articles
1
Sasiprapa Wattanavises, Atit Silsirivanit, Kanlayanee Sawanyawisuth, Ubon Cha’on, Sakda Waraasawapati, Waraporn Saentaweesuk, Sukanya Luang, Chalongchai Chalermwat, Chaisiri Wongkham, Sopit Wongkham. Increase of MAL-II Binding Alpha2,3-Sialylated Glycan Is Associated with 5-FU Resistance and Short Survival of Cholangiocarcinoma PatientsMedicina 2019; 55(12): 761 doi: 10.3390/medicina55120761
2
Septila Renata, Nitish Verma, Rama Krishna Peddinti. Surface-enhanced Raman spectroscopy as effective tool for detection of sialic acid as cancer biomarkerSpectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy 2024; : 125631 doi: 10.1016/j.saa.2024.125631
3
V. Pirgozliev, O. Oduguwa†, T. Acamovic, M.R. Bedford. Effects of dietary phytase on performance and nutrient metabolism in chickensBritish Poultry Science 2008; 49(2): 144 doi: 10.1080/00071660801961447
4
Bin Wang, Liang Chen, Hao-Teng Chang. Potential Diagnostic and Prognostic Biomarkers for Cholangiocarcinoma in Serum and BileBiomarkers in Medicine 2016; 10(6): 613 doi: 10.2217/bmm-2015-0062
5
Ewa Gruszewska, Lech Chrostek. Biomarkers in Liver DiseaseBiomarkers in Disease: Methods, Discoveries and Applications 2017; : 407 doi: 10.1007/978-94-007-7675-3_11
6
M. Grunnet, M. Mau-Sørensen. Serum tumor markers in bile duct cancer – a reviewBiomarkers 2014; 19(6): 437 doi: 10.3109/1354750X.2014.923048
7
Kanda Fanhchaksai, Kanchanok Kodchakorn, Peraphan Pothacharoen, Prachya Kongtawelert. Effect of sesamin against cytokine production from influenza type A H1N1-induced peripheral blood mononuclear cells: computational and experimental studiesIn Vitro Cellular & Developmental Biology - Animal 2016; 52(1): 107 doi: 10.1007/s11626-015-9950-7
8
Amir A. Rahnemai-Azar, Allison Weisbrod, Mary Dillhoff, Carl Schmidt, Timothy M. Pawlik. Intrahepatic cholangiocarcinoma: Molecular markers for diagnosis and prognosisSurgical Oncology 2017; 26(2): 125 doi: 10.1016/j.suronc.2016.12.009
9
Ewa Gruszewska, Lech Chrostek. Biomarkers in Liver DiseaseBiomarkers in Disease: Methods, Discoveries and Applications 2015; : 1 doi: 10.1007/978-94-007-7742-2_11-1
10
Xiaoqing Zhang, Peng Dou, Muhammad Luqman Akhtar, Fei Liu, Xibo Hu, Lijun Yang, Depeng Yang, Xiaohan Zhang, Yiqun Li, Shupei Qiao, Kai Li, Ran Tang, Chao Zhan, Yue Ma, Qixiang Cheng, Yan Bai, Fang Han, Huan Nie, Yu Li. NEU4 inhibits motility of HCC cells by cleaving sialic acids on CD44Oncogene 2021; 40(35): 5427 doi: 10.1038/s41388-021-01955-7
11
Rıza Yalçın, Asım Kart, Özlem Özmen, Esra Zeybek. Protective effects of resveratrol against fumonisin B1-induced liver toxicity in miceArchives of Industrial Hygiene and Toxicology 2023; 74(2): 115 doi: 10.2478/aiht-2023-74-3648
12
Andrés García-Sampedro, Pilar Acedo, Stephen P. Pereira. Diagnosis and Management of Cholangiocarcinoma2021; : 413 doi: 10.1007/978-3-030-70936-5_19
13
Alexander Ney, Andres Garcia-Sampedro, George Goodchild, Pilar Acedo, Giuseppe Fusai, Stephen P. Pereira. Biliary Strictures and Cholangiocarcinoma – Untangling a Diagnostic ConundrumFrontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.699401
14
Nabil M. Abdel-Hamid, Mohamed A. Morsy. Novel Biochemical Pathways for 5-Fluorouracil in Managing Experimental Hepatocellular Carcinoma in RatsJournal of Membrane Biology 2010; 234(1): 29 doi: 10.1007/s00232-010-9236-7
15
Mohammed M.H. Al-Gayyar, Mohamed A. Ebrahim, Mohamed E.E. Shams. Measuring serum levels of glycosaminoglycans for prediction and using viscum fraxini-2 for treatment of patients with hepatocellular carcinomaJournal of Pharmacy Research 2013; 7(7): 571 doi: 10.1016/j.jopr.2013.07.016